Halyard Health is a medical technology company focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The company delivers clinically-superior products and solutions in infection prevention, surgical solutions, respiratory health, digestive health, pain management and IV therapy.
Halyard Health sells its recognized brands and products in more than 100 countries, and holds leading market positions in multiple categories across the portfolio.
Formerly part of Kimberly-Clark, Halyard Health became an independent company headquartered in Alpharetta, Georgia on November 1, 2014. Halyard operates 12 global manufacturing facilities with 16,500 employees worldwide – generating approximately $1.7 billion in net revenues.
Halyard Health is traded on the New York Stock Exchange under the ticker symbol “HYH”.
To view the company website, click here.